Suchergebnisse - "Santana-Davila, Rafael"

PubPharm (54)

1

Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions

enthalten in: Science advances | 2024

von Hiatt, J. | Doebley, A. | Arnold, H. | +14

2

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

enthalten in: Cancer medicine | 2022

von Chalker, C. | Voutsinas, J. | Wu, Q. | +13

3

Chemo and Immuno-Therapeutic Options for Nonsmall Cell Lung Cancer Lung Cancer

enthalten in: The Surgical clinics of North America | 2022

von Santana-Davila, R.

4

High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors

enthalten in: Journal of palliative medicine | 2022

von Chalker, C. | Santana-Davila, R. | Voutsinas, J. | +13

5

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers : Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer

enthalten in: Advances in radiation oncology | 2022

von Bowen, S. | Hippe, D. | Thomas, H. | +14

6

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2021

von Ganti, A. | Loo, B. | Bassetti, M. | +31

7

Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01) : a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

enthalten in: The Lancet. Oncology | 2021

von Lakhani, N. | Chow, L. | Gainor, J. | +16

8

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma : survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

enthalten in: Nature medicine | 2021

von Forde, P. | Anagnostou, V. | Sun, Z. | +24

9

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer : The NRG-LU001 Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2021

von Skinner, H. | Hu, C. | Tsakiridis, T. | +17

CommentIn: JAMA Oncol. 2021 Sep 1;7(9):1341-1342. - PMID 34323949

10

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer

enthalten in: bioRxiv.org | 2021

von Bowen, S. | Hippe, D. | Thomas, H. | +14

1
2
3
4
5
6
Nächster »
[6]